Antimicrobial Resistance Practice Questions

Q: A 65-year-old male underwent emergency laparotomy for perforated duodenal ulcer 5 days ago. He now develops fever (38.5°C), productive cough, and increased oxygen requirement. Chest X-ray shows a new right lower lobe infiltrate. Gram stain of endotracheal aspirate shows Gram-negative bacilli, and culture grows lactose-fermenting colonies that are oxidase-negative and produce a metallic sheen on EMB agar. The isolate is resistant to ampicillin and third-generation cephalosporins but sensitive to cefoxitin (a cephamycin). Resistance is inhibited by clavulanic acid in disk synergy testing. The isolate is also resistant to fluoroquinolones, but sensitive to carbapenems and colistin. What is the most likely mechanism of antibiotic resistance in this organism?

Extended-spectrum beta-lactamase (ESBL) production. ***Extended-spectrum beta-lactamase (ESBL) production*** - **E. coli** with resistance to **third-generation cephalosporins** but sensitivity to **cefoxitin** (cephamycin) is classic for **ESBL production**. - The positive **disk synergy testing** with **clavulanic acid inhibition** is pathognomonic for **ESBL enzymes**, which are inhibited by beta-lactamase inhibitors. *AmpC beta-lactamase hyperproduction* - **AmpC producers** are typically resistant to **cefoxitin** (cephamycins), unlike this isolate which is sensitive. - **AmpC enzymes** are **NOT inhibited by clavulanic acid**, contradicting the positive disk synergy test described. *Carbapenemase production* - This mechanism is ruled out as the isolate is explicitly **sensitive to carbapenems** (imipenem, meropenem). - **Carbapenemase-producing Enterobacteriaceae** would show high-level resistance to all **carbapenem antibiotics**. *Porin channel mutation with efflux pump overexpression* - These mechanisms rarely provide the **high-level, specific resistance** to third-generation cephalosporins seen here. - **Efflux pumps** typically cause **low-level, multidrug resistance** patterns rather than the specific beta-lactam resistance profile described.

Q: A cluster of pneumonia cases is reported from a city with high mortality rate. Sputum cultures show gram-negative coccobacilli resistant to multiple antibiotics including carbapenems. Gene sequencing reveals blaNDM-1. What is the most critical factor contributing to this emerging resistance?

Horizontal gene transfer through plasmids. ***Horizontal gene transfer through plasmids*** - The **blaNDM-1** gene (New Delhi Metallo-beta-lactamase) is typically carried on highly mobile **plasmids**, enabling rapid dissemination between different bacterial species. - This mechanism is the most critical driver for the **global spread** of carbapenem resistance, often carrying multiple other resistance genes simultaneously. *Point mutations in chromosomal DNA* - While mutations can cause resistance to some drugs (like fluoroquinolones), they are **vertical** and generally slower than the rapid cluster outbreaks caused by **horizontal transfer**. - The **blaNDM-1** gene is an acquired genetic sequence, not a result of a singular point mutation in common **gram-negative coccobacilli** chromosomes. *Decreased porin expression* - Porin loss can lead to **carbapenem resistance** by preventing drug entry into the periplasm, often seen in *Pseudomonas* or *Klebsiella*. - However, this is a **structural modification** that usually works in synergy with enzymes rather than being the primary factor defined by the **blaNDM-1** gene. *Efflux pump mechanisms only* - Efflux pumps actively transport various antibiotics out of the cell, contributing to **multidrug resistance (MDR)**. - While they contribute to the phenotype, the question specifically identifies **blaNDM-1**, which is a **metallo-beta-lactamase enzyme** that enzymaticallly degrades the antibiotic, not a pump mechanism.

Q: Which of the following drugs should not be used to treat Klebsiella infection?

Ampicillin. ### Explanation The correct answer is **Ampicillin**. **1. Why Ampicillin is the correct answer:** *Klebsiella pneumoniae* possesses a **constitutive (intrinsic) resistance** to Ampicillin and Amoxicillin. This is due to the presence of chromosomally mediated **SHV-1 beta-lactamase** enzymes that hydrolyze these penicillins. Therefore, Ampicillin is clinically ineffective against *Klebsiella* species regardless of the strain's sensitivity profile in the lab. **2. Analysis of Incorrect Options:** * **B. Amikacin:** This is an Aminoglycoside often used as part of a combination therapy for serious Gram-negative infections, including *Klebsiella*. * **C. Imipenem:** A Carbapenem that remains one of the most potent drugs against *Klebsiella*, particularly for Extended-Spectrum Beta-Lactamase (ESBL) producing strains. However, resistance is rising due to Carbapenemases (KPC). * **D. Tigecycline:** A Glycylcycline used as a "reserve drug" for Multi-Drug Resistant (MDR) *Klebsiella*, including Carbapenem-Resistant Enterobacteriaceae (CRE). **3. High-Yield Clinical Pearls for NEET-PG:** * **Intrinsic Resistance:** Always remember that *Klebsiella* is naturally resistant to Ampicillin. Similarly, *Proteus mirabilis* is intrinsically resistant to Nitrofurantoin, and *Pseudomonas* is resistant to many common antibiotics like Tigecycline. * **ESBL Production:** *Klebsiella* is a frequent producer of ESBLs, which confer resistance to 3rd generation Cephalosporins (Ceftriaxone, Ceftazidime). The drug of choice for ESBL-producing *Klebsiella* is a **Carbapenem**. * **Morphology:** On MacConkey agar, *Klebsiella* produces large, mucoid, pink colonies (Lactose Fermenter) due to its prominent polysaccharide capsule.

Q: Enzyme inactivation is the main mode of resistance to which class of antibiotics?

Aminoglycosides. **Explanation** The primary mechanism of resistance to **Aminoglycosides** (e.g., Gentamicin, Amikacin) is the production of **Aminoglycoside Modifying Enzymes (AMEs)**. These bacterial enzymes (phosphorylases, adenyltransferases, and acetyltransferases) modify the antibiotic molecule, preventing it from binding to the 30S ribosomal subunit. While other mechanisms like efflux pumps and ribosomal mutations exist, enzyme inactivation is clinically the most significant and common mode of resistance. **Analysis of Incorrect Options:** * **Quinolones (e.g., Ciprofloxacin):** Resistance is primarily due to **target site mutations** in DNA gyrase (*gyrA*) and Topoisomerase IV (*parC*), or through decreased permeability and efflux pumps. * **Rifamycins (e.g., Rifampicin):** Resistance occurs almost exclusively through **mutations in the *rpoB* gene**, which encodes the beta-subunit of bacterial RNA polymerase, altering the drug's binding site. * **Glycopeptides (e.g., Vancomycin):** Resistance (seen in VRE) is due to **target site modification**, where the terminal D-Ala-D-Ala of the peptidoglycan precursor is replaced by D-Ala-D-Lac or D-Ala-D-Ser, reducing the drug's affinity. **High-Yield Clinical Pearls for NEET-PG:** * **Amikacin** is often the most resistant aminoglycoside to these enzymes because its side chain protects it from many AMEs. * **Beta-lactams** also utilize enzyme inactivation (Beta-lactamases) as a major mechanism, but among the options provided, Aminoglycosides are the classic example. * **Mnemonic for Aminoglycoside Resistance:** **A**cetylation, **P**hosphorylation, **A**denylation (**APA** enzymes).

Question 1

A 65-year-old male underwent emergency laparotomy for perforated duodenal ulcer 5 days ago. He now develops fever (38.5°C), productive cough, and increased oxygen requirement. Chest X-ray shows a new right lower lobe infiltrate. Gram stain of endotracheal aspirate shows Gram-negative bacilli, and culture grows lactose-fermenting colonies that are oxidase-negative and produce a metallic sheen on EMB agar. The isolate is resistant to ampicillin and third-generation cephalosporins but sensitive to cefoxitin (a cephamycin). Resistance is inhibited by clavulanic acid in disk synergy testing. The isolate is also resistant to fluoroquinolones, but sensitive to carbapenems and colistin. What is the most likely mechanism of antibiotic resistance in this organism?

Accepted Answer

Extended-spectrum beta-lactamase (ESBL) production

Answer

AmpC beta-lactamase hyperproduction

Answer

Carbapenemase production

Answer

Porin channel mutation with efflux pump overexpression

Question 2

A cluster of pneumonia cases is reported from a city with high mortality rate. Sputum cultures show gram-negative coccobacilli resistant to multiple antibiotics including carbapenems. Gene sequencing reveals blaNDM-1. What is the most critical factor contributing to this emerging resistance?

Accepted Answer

Horizontal gene transfer through plasmids

Answer

Point mutations in chromosomal DNA

Answer

Decreased porin expression

Answer

Efflux pump mechanisms only

Question 3

Which of the following drugs should not be used to treat Klebsiella infection?

Accepted Answer

Ampicillin

Answer

Amikacin

Answer

Imipenem

Answer

Tigecycline

Question 4

Enzyme inactivation is the main mode of resistance to which class of antibiotics?

Accepted Answer

Aminoglycosides

Answer

Quinolones

Answer

Rifamycins

Answer

Glycopeptides

Question 5

Which of the following is true regarding Methicillin-resistant Staphylococcus aureus (MRSA)?

Accepted Answer

Pulse field gel electrophoresis is useful in the investigation of an MRSA outbreak.

Answer

It is resistant to iodine solution.

Answer

It can be transmitted via the air-conditioning system.

Answer

It primarily causes deeper infections.

Antimicrobial Resistance — MCQs

Antimicrobial Resistance — MCQs

On this page

Practice by Chapter

Want unlimited practice?